Latest News and Press Releases
Want to stay updated on the latest news?
-
Münster, 29.04.2025 - Das Technologie-Start-up eeden, das eine hochinnovative Recyclingtechnologie für Textilien entwickelt hat, gibt den erfolgreichen Abschluss seiner Series-A-Finanzierungsrunde in...
-
Münster, 29.04.2025 - German tech startup eeden, which has developed a groundbreaking textile recycling technology, announces the completion of its €18 million Series A funding round. The round was...
-
BRANFORD, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immunotherapy company developing first-in-category, multifunctional T Cell engager biotherapeutics to address unmet...
-
The company will unveil new AI-powered solutions designed to tackle inefficiencies that existing systems and services fail to addressPando CEO to present the impact of AI in the future of logistics on...
-
Novel paradigm for therapeutics based on RNA splicing modulationLead program in Huntington’s disease Denmark – Odense – 07/01/2025 – Inverna Therapeutics, a novel Danish biotech company at the...
-
COMMUNIQUÉ DE PRESSE | Paris, France - 3 décembre 2024 Smart Immune, société de biotechnologie en stade clinique, et CELLforCURE by SEQENS, entreprise de développement et de fabrication en...
-
PRESS RELEASE | Paris, France – December 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for...
-
The Silicon Review Features CyberAI as a Top Cybersecurity to watch in 2024 Highlighting Strategic Global Expansion
-
La phase I d'escalade de dose de ReSET-02 chez des adultes souffrant de cancers hématologiques est terminée.Le segment randomisé de la phase II de cet essai est en cours.Aucune toxicité limitant la...
-
ReSET-02 dose escalation Phase I is completedPhase II PoC randomized segment is starting No dose-limiting toxicities, no safety or tolerability issuesThe highest dose is to be used in both...